General Data has announced that it has acquired Triangle Biomedical Sciences Inc., (TBS) of Durham, North Carolina, a leading manufacturer and supplier of instrumentation, reagents and consumables for the clinical and research pathology marketplace. With this acquisition, General Data Healthcare will now offer an expanded and comprehensive portfolio of equipment, solutions and supplies that enable histology laboratories to utilize advanced products and technologies for specimen identification, preparation, processing, tracking and storage.
“The addition of TBS significantly broadens General Data Healthcare’s product portfolio with very high quality instrumentation, reagents and consumables, as well as expands our team of product engineers and industry specialists. Together, we will offer a powerful combination of product, industry and user expertise that will be a significant benefit to our customers,” said Peter Wenzel, President and Chief Executive Officer of General Data.